Minimed Group, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
MiniMed Group, Inc. announced a 16.6% increase in net sales for the first quarter of fiscal year 2027, driven by robust performance in CGM and pump segments, alongside strategic product advancements.
NASDAQ
MiniMed Group reports Q3 2026 net sales of $790 million, reflecting a 15% increase, alongside a net loss of $111 million driven by restructuring and litigation charges.